SPP1 <sup>+</sup> TAM: CD8 <sup>+</sup> T Cell Crosstalk Associates with Blocking Radiotherapy Efficacy in Lung Cancer

Radiotherapy (RT) is a cornerstone treatment for non-small cell lung cancer (NSCLC), but its efficacy is often limited by immune suppression in the tumor microenvironment. In this study, we identified SPP1 as a key factor up-regulated after RT, mainly expressed by immunosuppressive macrophages. Single-cell RNA sequencing and in vivo models showed that SPP1<sup>+</sup> macrophages inhibit CD8<sup>+</sup> T cell infiltration and correlate with poor prognosis. Targeting SPP1 in macrophages enhanced RT efficacy, reduced tumor burden, and restored antitumor immunity. In summary, combining RT with SPP1<sup>+</sup> macrophage-targeted intervention may serve as a promising strategy to overcome immune-mediated radioresistance and enhance therapeutic efficacy in NSCLC.

Authors

Institutions

Publication Details

Journal
Research
Published
2025-01-01
DOI
https://doi.org/10.34133/research.0851
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SPP1 + TAM: CD8 + T Cell Crosstalk Associates with Blocking Radiotherapy Efficacy in Lung Cancer

Bufu Tang, Yuzhao Jin, Yifei Ma, Songhua Cai et al.
1 citations
Research
Cancer Immunotherapy and Biomarkers
1.05
article

SPP1 + TAM: CD8 + T Cell Crosstalk Associates with Blocking Radiotherapy Efficacy in Lung Cancer

Bufu Tang, Yuzhao Jin, Yifei Ma, Songhua Cai, Wenjun Mao, Peng Luo, Zhijun Shen, Xiaojie Zhang, Yuan Zhuang, Jinhua Luo, Lingling Wang, Qing Li, Dandan Guo, Zhao Xie, Chan Gao, Rong Gao, N.T. Hang
article en
1 citations

Abstract

Radiotherapy (RT) is a cornerstone treatment for non-small cell lung cancer (NSCLC), but its efficacy is often limited by immune suppression in the tumor microenvironment. In this study, we identified SPP1 as a key factor up-regulated after RT, mainly expressed by immunosuppressive macrophages. Single-cell RNA sequencing and in vivo models showed that SPP1<sup>+</sup> macrophages inhibit CD8<sup>+</sup> T cell infiltration and correlate with poor prognosis. Targeting SPP1 in macrophages enhanced RT efficacy, reduced tumor burden, and restored antitumor immunity. In summary, combining RT with SPP1<sup>+</sup> macrophage-targeted intervention may serve as a promising strategy to overcome immune-mediated radioresistance and enhance therapeutic efficacy in NSCLC.

ResearchVol. 8
Shanghai Medical College of Fudan University (CN), Dalian Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Fudan University (CN), Wenzhou Medical University (CN), National Cancer Center (US), Second Affiliated Hospital of Chongqing Medical University (CN), Zhujiang Hospital (CN), Zhongshan Hospital (CN), First Affiliated Hospital of Dalian Medical University (CN), Wuxi People's Hospital (CN), China Medical University (CN)
Good health and well-being
Openalex Percentile: Top 19%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.